Skip to Main Content

View Public Comments for Autologous Blood-Derived Products for Chronic Non-Healing Wounds

Use the browser below to select the Comment Period for which you would like to view the comments for the selected document. You can use the alphabetical links above the results table to jump to comments submitted by a commenter whose last name starts with that letter. Select the ‘Expand All Comments’ link to view all the full comments, and click the ‘Collapse All Comments’ link to view only the abstract for all comments. Select the ‘More’ link in the Comment to view the full text of the specific comment in a new window.
The first (earliest) set of comments are displayed by default in the Public Comment Results section. To view additional Comment Periods, use the radio button options and select the "Submit" button.
An asterisk (*) indicates a required field.

      Select one period.



[121 Comments]
Page 1 of 5
FirstPrev12345NextLast
First character of titleCommenterComment Information
A
Alexander, Robert Title: Physician and Surgeon
Organization: N/A Private Practice
Date: 11/22/2011
Comment:
This comment is written regarding the utilization of PRP concentrates in conjunction with surgical wound care in chronic ulcerations, decubitus ulcers, diabetic ulcers, and deep burn ulcerations. I am a plastic-reconstructive surgeon with more More opens in new window
A
Arnzen, Tom Date: 12/05/2011
Comment:
As a practicing perfusionist and President of an autologous blood maanagement company I have had the unique pleasure of seeing the results first hand of the benefits of platelet concentrate on multiple wound procedures. From diabetic ulcerations More opens in new window
A
Austin, Millie Date: 11/23/2011
Comment:
[PHI Redacted] has had diabetes for 11 years and for the last 4 years has had a diabetic ulcer on the bottom of his foot. Within in the last 3 years there was no progress in healing and he had the AutoGel procedure done and the More opens in new window
A
Austin, Millie Date: 11/25/2011
Comment:
I would like to clarify my previous comment of 11/23/11. The AutoGel treatment was stopped due to internal politics in the medical facility despite the good outcomes that we had and the other patients were More opens in new window
B
Barre, Joe Date: 12/06/2011
Comment:
Wound care most certainly will benefit from the use of PRP. I have tried to convince my institution of its benefits, but without reimbursement, it seems the science does not matter. The patients need More opens in new window
B
Beriou, Judy Title: Owner
Organization: HRN
Date: 11/28/2011
Comment:
To Whom it May Concern: I am an RN who worked with autologous blood-dervied products for chronic non-healing wounds when I was part of a team that worked with clinicians in patient applications. Even as a company representative, I was More opens in new window
B
Beriou RN, MHA, CWS, Judy Title: Owner
Organization: HRN
Date: 12/01/2011
Comment:
In reviewing my previous comment on the value of PRP in treatment of chronic non-healing wounds, I felt that it is important to cite the data that came from Cytomedix' study. I have reviewed the Cytomedix data and wish to repeat the outcomes More opens in new window
B
Bishop, Jr., Rep. Sanford D. Title: Member of Congress
Date: 12/05/2011
Comment:

December 5, 2011

Lisa Eggleston, RN, MS, Lead Analyst
Centers for Medicare and Medicaid Services
Office Of Clinical Standards And Quality
Coverage and Analysis Group
7500 Security Boulevard
Mail Stop: More opens in new window

B
Bocchino, Carmella Title: EVP, Clinical Affairs and Strategic Planning
Organization: America's Health Insurance Plans (AHIP)
Date: 12/07/2011
Comment:

December 7, 2011

Lisa Eggleston, RN, MS
Lead Analyst
Centers for Medicare and Medicaid Services
Mail Stop C1-09-06
7500 Security Boulevard
Baltimore, Maryland 21244-1850

Dear More opens in new window

B
Borris-Hale, Cathy Title: Chief Nursing Officer
Organization: Specilaty Hospital of Washington - Hadley
Date: 12/05/2011
Comment:
November 29, 2011 Dear Sir/Madam: I am the Chief Nursing Officer of a Long Term Acute Care hospital. We have used AutoloGel PRP to treat wound patients in our facility. Consistently, we find that wounds that have More opens in new window
B
Brandt, Robert Title: Chief Medical Officer
Organization: Orogen Biosciences, Inc.
Date: 11/21/2011
Comment:
Once again the CMS has decided to review the clinical efficacy and merits of platelet rich plasma (PRP) use on chronic wounds in the Medicare patient population. For this, I applaud you! Our group has been utilizing prp for over 15 years and has More opens in new window
B
Brown, Susan Title: CAPT, USPHS, FNP-BC, CWOCN
Organization: USPHS
Date: 12/01/2011
Comment:
I have used Autologel in my wound healing practice for three years. It is an efficacious and efficient adjunct therapy that facilitates and potentiates wound healing. The process for making platelet rich plasma (PRP) gel is a safe procedure that More opens in new window
C
Caillouet-O'Neal, Cammie Title: Wound care nurse
Organization: Promise Hospital LTAC
Date: 11/29/2011
Comment:
I am currently involved in treating patients with Safeblood and have been for the past eight months. I have been involved in the treatment and care of 4 patients with chronic wounds. 3 with great outcomes. The 4th was just treated 2 weeks ago. More opens in new window
C
Carman, Donna Title: Deputy Chief of Surgery
Organization: Phoenix Indian Medical Center, Public Health Service
Date: 12/02/2011
Comment:
My clinical experience with blood derived products (PRP) for chronic non healing wounds has been positive. As as a practicing general surgeon I have experienced 75% of patients with wounds that have undermining or a sinus track respond to PRP. More opens in new window
C
Carter, Marissa Title: President
Organization: Strategic Solutions, Inc.
Date: 12/01/2011
Comment:
I am not a practicing physician but have worked in wound care research for many years in the fields of basic wound care and advanced therapies. With appropriate care some 65-75% of chronic wounds will heal within 1 year. However, healing More opens in new window
C
Clark, Justin Title: Student of Cardiovascular Perfusion
Organization: Midwestern University
Date: 12/02/2011
Comment:
I am a Perfusion student currently on my clinical rotations. After reading various studies, I was curious of how effective PRP therapy actually was. I have now witnessed plenty of PRP therapies utilized and am thrilled with the positive outcomes More opens in new window
C
Coleman, Ann Title: AVP, Nursing Services
Organization: National HealthCare Corp.
Date: 11/22/2011
Comment:
As a nurse practicing in Long Term Care, I support a national coverage determination that would include autologous blood derived products for wound healing. Having observed the healing capabilities of this process and product on chronic More opens in new window
C
Connolly, John Title: Podiatrist
Date: 11/18/2011
Comment:
I am submitting my comments regarding platelet derived growth factor in the care of chronic non-healing wounds as an initial trial at our institution proved extraordinarily successful (3 patients over 2 weeks 70% healing in wounds > 1 year More opens in new window
C
Cordisco, M.S. CCP, Michael Title: Chief of Perfusion
Organization: Stamford Hospital
Date: 12/06/2011
Comment:
I have been a practicing Perfusionist and a member of the American Board of Cardiovascular Perfusion for 14 years. During that time I have seen the widespread and increasing use of platelet rich (PRP) and platelet poor (PPP) plasma More opens in new window
C
couper, melinda Title: perfusionist
Organization: Southern Ohio Medical Center
Date: 12/05/2011
Comment:
I am a perfusionist working in a rural community in which the use of platelet gel has had an extreme effect on my patients. Due to the fact that medicare does not reimburse for this service, we have had to select our patients very carefully. Some More opens in new window
D
de Leon, MD, Jean Title: Medical Director Wound Care
Organization: Baylor Specialty Hospital
Date: 11/29/2011
Comment:
Autologous Blood-Derived Products for Chronic Non-Healing Wounds I have been using Platelet Rich plasma Gel (PRPG) since January of 2009. I have trialed the technology in various types of wounds to evaluate the clinical benefits. I published More opens in new window
d
Dellinger, Richard Title: Podiatrist
Organization: Foot and Ankle Associates
Date: 11/27/2011
Comment:
I have provided this therapy, supplied by Safeblood Technologies, for 10 years. I have found this therapy to be incredibly useful for many of my patients. There is no doubt in my mind that may limbs were salvaged as a result of them receiving this More opens in new window
d
DeSilva, Kathleen Date: 12/03/2011
Comment:
[PHI Redacted] is a C1 quadriplegic who has had chronic nonhealing wounds on her left ischium for over 10 years. She tried the Autologel procedure for a very deep tunnel in that area and experienced considerable success. Over a More opens in new window
d
Desotelle, Robert Title: CEO
Organization: Asheville Specialty Hospital
Date: 12/09/2011
Comment:
We are a Long-Term Care Hospital (LTCH) and people with wounds make up a significant portion of our patient population. We are always looking for way to improve wound care outcomes in a cost effective manner. Prior practice was what I would a More opens in new window
d
Desotelle, CEO, Robert Organization: Asheville Specialty Hospital
Date: 12/09/2011
Comment:

We are a Long-Term Care Hospital (LTCH) and people with wounds make up a significant portion of our patient population. We are always looking for way to improve wound care outcomes in a cost effective manner. Prior practice was More opens in new window

Page 1 of 5
FirstPrev12345NextLast
4